Alcohol septal ablation

Alcohol septal ablation

Alcohol septal ablation is a percutaneous, minimally-invasive treatment performed by an interventional cardiologist to relieve symptoms and improve functional status in severely symptomatic patients with hypertrophic cardiomyopathy (HCM) who meet strict clinical, anatomic and physiologic selection criteria. In carefully selected patients, when performed by an experienced interventional cardiologist, the procedure is successful in relieving symptoms in over 90% of patients.

Hypertrophic cardiomyopathy is a condition of the heart muscle which grows abnormally thick, in the absence of a physiologic cause such as hypertension (high blood pressure) or aortic valve disease. In a subset of patients with hypertrophic obstructive cardiomyopathy, thickening of the heart muscle in a particular part of the interventricular septum causes obstruction to blood being ejected from the left ventricle.

Alcohol septal ablation is a technique designed to reduce the obstruction to blood being ejected from the heart; the technique creates a small controlled heart attack, killing the area of heart muscle responsible for the obstruction, and eventually causing it to become less thick.

History

Alcohol septal ablation was first performed in Britain at the Royal Brompton Hospital by Ulrich Sigwart in 1994. Since that time, it has quickly gained favor among physicians and patients alike due to its minimally-invasive nature, avoiding general anesthesia, lengthy recuperation and other complications associated with open heart surgery (septal myectomy).

Technique

Alcohol septal ablation is performed in the cardiac catheterization laboratory, and should only be performed by interventional cardiologists with specific training in the procedure. As such, it is only available in a few institutions. The technique is similar to coronary angioplasty, and utilizes similar equipment. Using wires and balloons to localize the septal artery feeding the diseased muscle, a small amount of absolute alcohol is infused into the artery to produce a small heart attack. Patients typically experience mild chest discomfort during the procedure, which takes approximately 30 minutes to complete. Analgesics and mild sedatives are administered as needed. Patients typically are maintained in the hospital for three to four days to monitor for any complications, including need for permanent pacemaker in 5-10%.

Outcomes

Relief of obstruction is noted immediately in the majority of appropriately selected patients. Clinical success is defined as a 50% or more reduction in peak gradient across the outflow tract, predicting continued improvement in gradient and cardiac remodeling over the ensuing 1 to 2 years. Over 90% of patients experience a successful procedure, with improvement in outflow tract gradient and mitral regurgitation. Patients typically report progressive reduction in symptoms, including improved shortness of breath, lightheadedness and chest pain. Serial echocardiograms are routinely obtained to follow the cardiac remodeling over time, and document reduction in outflow tract gradient.

When compared to surgical myectomy, similar outcomes are noted out to approximately 5 years.1 However, a prospective, randomized trial has not been performed. Despite initial concerns regarding long-term arrhythmic potential of alcohol septal ablation, no increased risk has been noted to date. It is important to note that patients who fail to respond to alcohol septal ablation may still be candidates for surgical myectomy. Likewise, patients who fail surgical myectomy may still respond to alcohol septal ablation.2 Which patients are best served by surgical myectomy, alcohol septal ablation, or medical therapy is an important topic and one which is intensely debated in medical scientific circles.3

References

1. Ralph-Edwards A, Woo A, McCrindle B, Shapero J, Schwartz L, Rakowski H, Wigle E, Williams W (2005). "Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score". J Thorac Cardiovasc Surg 129 (2): 351-8. PMID 15678046.
2. Juliano N, Wong SC, Naidu SS (2005). "Alcohol septal ablation for failed sugical myectomy". J Invasive Cardiology 17 (10): 569-71. PMID 16204755.

3. Heldman AW, Wu KC, Abraham TP, Cameron DE. Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round. J Am Coll Cardiol. 2007 Jan 23;49(3):358-60. PMID 17239718.


Wikimedia Foundation. 2010.

Игры ⚽ Поможем решить контрольную работу

Look at other dictionaries:

  • Septal myectomy — is a cardiac surgery treatment for hypertrophic cardiomyopathy (HCM). Septal myectomies have been successfully performed for more than 25 years.OutcomesSeptal myectomy is associated with a low perioperative mortality and a high late survival rate …   Wikipedia

  • Hypertrophic cardiomyopathy — Classification and external resources ICD 10 I42.1–I42.2 ICD 9 …   Wikipedia

  • Hypertrophe Kardiomyopathie — Die Hypertrophe Kardiomyopathie (auch: hypertrophische Kardiomyopathie; HCM; früher: idiopathische hypertrophe subaortale Stenose; IHSS) ist eine angeborene Erkrankung und gehört zur großen Gruppe der Kardiomyopathien (gr. kardio (καρδία) Herz,… …   Deutsch Wikipedia

  • Minimaze procedure — Intervention ICD 9 CM 37.33 The mini maze procedures are cardiac surgery procedures intended to cure atrial fibrillation (AF), a common disturbance of heart rhythm. They are procedures derived from the original maze proce …   Wikipedia

  • Cryoablation — Intervention ICD 9 CM 37.33, 37.34 …   Wikipedia

  • Surgery — This article is about the medical specialty. For other uses, see Surgery (disambiguation). A cardiothoracic surgeon performs a mitral valve replacement at the Fitzsimons Army Medical Center. Surgery (from the Greek …   Wikipedia

  • Jatene procedure — Intervention ICD 9 CM 35.84 The Jatene procedure, or arterial switch, is an open heart surgical procedure used to correct dextro transposition of the great arteries (d TGA); its development was …   Wikipedia

  • Artificial pacemaker — Cardiac resynchronization therapy and CRT (Cardiac Resynchronization Therapy) redirect here. For the device termed a CRT D, see Implanted cardiac resynchronization device. For other uses, see Pacemaker (disambiguation). A pacemaker, scale in… …   Wikipedia

  • Norwood procedure — Intervention Diagram of a healthy heart and one suffering from Hypoplastic left heart syndrome. In the heart on the right, note the near absence of the left ventricle, which normally provides systemic circulation. In the Norwood procedur …   Wikipedia

  • Blalock–Taussig shunt — Intervention The arch of the aorta and its branches. In the Blalock–Taussig shunt, blood from the subclavian artery or carotid artery (in red at the top) is redirected to the pulmonary artery (in blue near the center) …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”